...
首页> 外文期刊>Clinical cancer research: an official journal of the American Association for Cancer Research >Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers
【24h】

Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

机译:通过整合临床和分子预后标志物对中低风险神经母细胞瘤患者的风险评估和治疗分层进行修订

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To optimize neuroblastoma treatment stratification, we aimed at developing a novel risk estimation system by integrating gene expression-based classification and established prognostic markers.
机译:目的:为了优化神经母细胞瘤的治疗分层,我们旨在通过整合基于基因表达的分类和建立预后标志物来开发新型风险评估系统。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号